These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

343 related items for PubMed ID: 11324434

  • 1. Colorectal cancer and non-steroidal anti-inflammatory drugs.
    Ota S, Bamba H, Kato A.
    Acta Pharmacol Sin; 2000 May; 21(5):391-5. PubMed ID: 11324434
    [Abstract] [Full Text] [Related]

  • 2. COX-2, NSAIDs and human neoplasia. Part I: Colorectal neoplasms.
    Nasir A, Fernandez PM, Chughtai OR, Kaiser HE.
    In Vivo; 2002 May; 16(6):501-9. PubMed ID: 12494894
    [Abstract] [Full Text] [Related]

  • 3. Prevention of colorectal cancer through the use of COX-2 selective inhibitors.
    Peek RM.
    Cancer Chemother Pharmacol; 2004 Sep; 54 Suppl 1():S50-6. PubMed ID: 15309515
    [Abstract] [Full Text] [Related]

  • 4. [Cyclooxygenase(COX)-2-inhibition in the prevention and treatment of colorectal carcinoma].
    Tuynman JB, Hulscher JB, Steller EP, van Lanschot JJ, Richel DJ.
    Ned Tijdschr Geneeskd; 2003 Nov 08; 147(45):2207-12. PubMed ID: 14640057
    [Abstract] [Full Text] [Related]

  • 5. Use of NSAIDs for the chemoprevention of colorectal cancer.
    Herendeen JM, Lindley C.
    Ann Pharmacother; 2003 Nov 08; 37(11):1664-74. PubMed ID: 14565811
    [Abstract] [Full Text] [Related]

  • 6. Prostaglandin H synthases, nonsteroidal anti-inflammatory drugs, and colon cancer.
    Levy GN.
    FASEB J; 1997 Mar 08; 11(4):234-47. PubMed ID: 9068612
    [Abstract] [Full Text] [Related]

  • 7. The prevention of colorectal cancer by aspirin use.
    Giovannucci E.
    Biomed Pharmacother; 1999 Aug 08; 53(7):303-8. PubMed ID: 10472428
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. An introduction to aspirin, NSAids, and COX-2 inhibitors for the primary prevention of cardiovascular events and cancer and their potential preventive role in bladder carcinogenesis: part II.
    Moyad MA.
    Semin Urol Oncol; 2001 Nov 08; 19(4):306-16. PubMed ID: 11769882
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. COX-2: a molecular target for colorectal cancer prevention.
    Brown JR, DuBois RN.
    J Clin Oncol; 2005 Apr 20; 23(12):2840-55. PubMed ID: 15837998
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The potential of non-steroidal anti-inflammatory drugs (NSAIDs) for colorectal cancer prevention.
    Bertagnolli MM.
    J Surg Oncol; 2003 Nov 20; 84(3):113-9. PubMed ID: 14598353
    [No Abstract] [Full Text] [Related]

  • 18. Early expression of cyclo-oxygenase-2 during sporadic colorectal carcinogenesis.
    Hao X, Bishop AE, Wallace M, Wang H, Willcocks TC, Maclouf J, Polak JM, Knight S, Talbot IC.
    J Pathol; 1999 Feb 20; 187(3):295-301. PubMed ID: 10398082
    [Abstract] [Full Text] [Related]

  • 19. Nonsteroidal anti-inflammatory drugs (NSAIDs) in the prevention of colorectal cancer.
    Stockbrügger RW.
    Eur J Cancer Prev; 1999 Dec 20; 8 Suppl 1():S21-5. PubMed ID: 10772414
    [Abstract] [Full Text] [Related]

  • 20. [Clinical application of cyclooxygenase-2 inhibitors].
    Dzielska-Olczak M, Olczak S.
    Pol Merkur Lekarski; 2001 Jun 20; 10(60):480-2. PubMed ID: 11503270
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.